Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.

Angiotensin-Converting Enzyme 2 COVID-19 Humans Pandemics Peptidyl-Dipeptidase A / genetics SARS-CoV-2 Spike Glycoprotein, Coronavirus
ACE2 Angiotensin converting enzyme 2 Bat-SARS-CoV COVID-19 Receiver connection range SARS-CoV SARS-CoV-2 SARS-CoV-like Spike protein

Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2021
Historique:
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 6 3 2021
Statut: ppublish

Résumé

Following the outbreaks of SARS-CoV in 2002 and MERS-CoV in 2012, the COVID-19 pandemic caused by the SARS-CoV-2 virus has become an increasing threat to human health around the world. Numerous studies have shown that SARS-CoV-2 appears similar to the SARS-CoV as it uses angiotensin converting enzyme 2 (ACE2) as a receptor to gain entry into cells. The main aims of this scoping review were to identify the primary hosts of coronaviruses, the relationship between the receptor binding domain of coronaviruses and ACE2, the organ specificity of ACE2 expression compared with clinical manifestations of the disease, and to determine if this information can be used in the development of novel treatment approaches for the COVID-19 pandemic.

Identifiants

DOI: 10.1007/978-3-030-59261-5_5 PMID: 33656713
pubmed: 33656713
doi: 10.1007/978-3-030-59261-5_5
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
Peptidyl-Dipeptidase A EC 3.4.15.1
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-68

Références

Sanjuán R, Domingo-Calap P (2016) Mechanisms of viral mutation. Cell Mol Life Sci 73(23):4433–4448
pubmed: 27392606 pmcid: 5075021 doi: 10.1007/s00018-016-2299-6
Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17(3):181–192
pubmed: 30531947 doi: 10.1038/s41579-018-0118-9
Lim YX, Ng YL, Tam JP, Liu DX (2016) Human coronaviruses: a review of virus-host interactions. Diseases 4(3):26. https://doi.org/10.3390/diseases4030026
doi: 10.3390/diseases4030026 pmcid: 5456285 pubmed: 5456285
https://www.cdc.gov/coronavirus/types.html
https://www.who.int/ith/diseases/sars/en/
https://www.who.int/emergencies/mers-cov/en/
Li H, Liu SM, Yu XH, Tang SL, Tang CK (2020) Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents 55(5):105951. https://doi.org/10.1016/j.ijantimicag.2020.105951
doi: 10.1016/j.ijantimicag.2020.105951 pubmed: 32234466 pmcid: 7139247
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
Yuki K, Fujiogi M, Koutsogiannaki S (2020) COVID-19 pathophysiology: a review. Clin Immunol 215:108427. https://doi.org/10.1016/j.clim.2020.108427
doi: 10.1016/j.clim.2020.108427 pubmed: 32325252 pmcid: 32325252
Belouzard S, Millet JK, Licitra BN, Whittaker GR (2012) Mechanisms of coronavirus cell entry mediated by the viral spike protein.Viruses 4(6):1011-1033
Turner AJ, Hiscox JA, Hooper NM (2004) ACE2: from Vasopeptidase to SARS virus receptor. Trends Pharmacol Sci 25(6):291–294
pubmed: 15165741 pmcid: 7119032 doi: 10.1016/j.tips.2004.04.001
Hofmann H, Pöhlmann S (2004) Cellular entry of the SARS coronavirus. Trends Microbiol 12(10):466–472
pubmed: 15381196 pmcid: 7119031 doi: 10.1016/j.tim.2004.08.008
Kruse RL (2020) Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Res 9:72. https://doi.org/10.12688/f1000research.22211.2
doi: 10.12688/f1000research.22211.2 pubmed: 32117569 pmcid: 7029759
Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B (2020) Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci 12(1):9. https://doi.org/10.1038/s41368-020-0075-9
doi: 10.1038/s41368-020-0075-9 pubmed: 32127517 pmcid: 7054527
Sun Z, Thilakavathy K, Kumar SS, He G, Liu SV (2020) Potential factors influencing repeated SARS outbreaks in China. Int J Environ Res Public Health 17(5):1633. https://doi.org/10.3390/ijerph17051633
doi: 10.3390/ijerph17051633 pmcid: 7084229 pubmed: 7084229
Kannan S, Shaik Syed Ali P, Sheeza A, Hemalatha K (2020) COVID-19 (novel coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci 24(4):2006–2011
pubmed: 32141569
Lambert DW, Clarke NE, Turner AJ (2010) Not just angiotensinases: new roles for the angiotensin-converting enzymes. Cell Mol Life Sci 67(1):89–98
pubmed: 19763395 doi: 10.1007/s00018-009-0152-x
Zisman LS (2005) ACE and ACE2: a tale of two enzymes. Eur Heart J 26(4):322–324
pubmed: 15671047 pmcid: 7108503 doi: 10.1093/eurheartj/ehi043
Magrone T, Magrone M, Jirillo E (2020) Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target - a perspective. Endocr Metab Immune Disord Drug Targets. https://doi.org/10.2174/1871530320666200427112902 . Online ahead of print
Sutton TC, Subbarao K (2015) Development of animal models against emerging coronaviruses: from SARS to MERS coronavirus. Virology 479-480:247–258
pubmed: 25791336 doi: 10.1016/j.virol.2015.02.030
Kuhn J, Li W, Choe H, Farzan M (2004) Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol Life Sci 61(21):2738–2743
pubmed: 15549175 pmcid: 7079798 doi: 10.1007/s00018-004-4242-5
Heller LK, Gillim-Ross L, Olivieri ER (2006) Wentworth DE (2006) Mustela vison ACE2 functions as a receptor for SARS-coronavirus. Adv Exp Med Biol 581:507–510
pubmed: 17037586 pmcid: 7123197 doi: 10.1007/978-0-387-33012-9_90
de Lang A, Osterhaus AD, Haagmans BL (2006) Interferon-γ and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. Virology 353(2):474–481
pubmed: 16860835 pmcid: 7111939 doi: 10.1016/j.virol.2006.06.011
Huang I-C, Bosch BJ, Li F, Li W, Lee KH, Ghiran S et al (2006) SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem 281(6):3198–3203
pubmed: 16339146 doi: 10.1074/jbc.M508381200
Xu L, Zhang Y, Liu Y, Chen Z, Deng H, Ma Z et al (2009) Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus. J Gen Virol 90(11):2695–2703
pubmed: 19625462 doi: 10.1099/vir.0.013490-0
Yoshikawa N, Yoshikawa T, Hill T, Huang C, Watts DM, Makino S et al (2009) Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2. J Virol 83(11):5451–5465
pubmed: 19297479 pmcid: 2681954 doi: 10.1128/JVI.02272-08
To K, Lo AW (2004) Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol 203(3):740–743
pubmed: 15221932 pmcid: 7167902 doi: 10.1002/path.1597
Mossel EC, Huang C, Narayanan K, Makino S, Tesh RB, Peters C (2005) Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication. J Virol 79(6):3846–3850
pubmed: 15731278 pmcid: 1075706 doi: 10.1128/JVI.79.6.3846-3850.2005
Ge XY, Li JL, Yang XL, Chmura AA, Zhu G, Epstein JH et al (2013) Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503(7477):535–538
pubmed: 24172901 pmcid: 24172901 doi: 10.1038/nature12711
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X et al (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12(1):1–5
doi: 10.1038/s41368-019-0067-9
Yan R, Zhang Y, Guo Y, Xia L, Zhou Q (2020) Structural basis for the recognition of the 2019-nCoV by human ACE2. bioRxiv. https://doi.org/10.1101/2020.02.19.956946
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46(4):586–590
pubmed: 32125455 doi: 10.1007/s00134-020-05985-9
Wang PH (2020) Increasing host cellular receptor—angiotensin-converting enzyme 2 (ACE2) expression by coronavirus may facilitate 2019-nCoV infection. bioRxiv. https://doi.org/10.1101/2020.02.24.963348
Inoue Y, Tanaka N, Tanaka Y, Inoue S, Morita K, Zhuang M et al (2007) Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J Virol 81(16):8722–8729
pubmed: 17522231 pmcid: 1951348 doi: 10.1128/JVI.00253-07
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B et al (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat Med 11(8):875–879
pubmed: 16007097 pmcid: 7095783 doi: 10.1038/nm1267
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965):450–454
pubmed: 14647384 pmcid: 7095016 doi: 10.1038/nature02145
Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J et al (2005) ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol 79(23):14614–14621
pubmed: 16282461 pmcid: 1287568 doi: 10.1128/JVI.79.23.14614-14621.2005
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052
doi: 10.1016/j.cell.2020.02.052 pubmed: 32142651 pmcid: 32142651
Lin W, Hu L, Zhang Y, Ooi JD, Meng T, Jin P et al (2020) Single-cell analysis of ACE2 expression in human kidneys and bladders reveals a potential route of 2019-nCoV infection. bioRxiv. https://doi.org/10.1101/2020.02.08.939892
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W (2020) Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. https://doi.org/10.1101/2020.01.26.919985
Li M, Chen L, Zhang J, Xiong C, Li X (2020) The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One 15(4):e0230295. https://doi.org/10.1371/journal.pone.0230295
doi: 10.1371/journal.pone.0230295 pubmed: 32298273 pmcid: 7161957
Deng YY, Zheng Y, Cai GY, Chen XM, Hong Q (2020) Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-nCoV. Chin Med J 133(9):1129–1131
pubmed: 32118645 pmcid: 7213623 doi: 10.1097/CM9.0000000000000783
Li GM, Li YG, Yamate M, Li S-M, Ikuta K (2007) Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes Infect 9(1):96–102
pubmed: 17194611 doi: 10.1016/j.micinf.2006.10.015
Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S et al (2020) Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor. bioRxiv. https://doi.org/10.1101/2020.02.19.956235
Li K, Yip C, Hon C, Lam C, Zeng F, Leung F (2012) Characterisation of animal angiotensin-converting enzyme 2 receptors and use of pseudotyped virus to correlate receptor binding with susceptibility of SARS-CoV infection. Hong Kong Med J 18:35–38
pubmed: 22865222
Li R, Qiao S, Zhang G (2020) Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV. J Inf Secur 80(4):469–496
Demogines A, Farzan M, Sawyer SL (2012) Evidence for ACE2-utilizing coronaviruses (CoVs) related to severe acute respiratory syndrome CoV in bats. J Virol 86(11):6350–6353
pubmed: 22438550 pmcid: 3372174 doi: 10.1128/JVI.00311-12
Zamoto A, Taguchi F, Fukushi S, Morikawa S, Yamada YK (2006) Identification of ferret ACE2 and its receptor function for SARS-coronavirus. Adv Exp Med Biol 581:519–522
pubmed: 17037589 pmcid: 7123533 doi: 10.1007/978-0-387-33012-9_93
Wong SK, Li W, Moore MJ, Choe H, Farzan M (2004) A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 279(5):3197–3201
pubmed: 14670965 doi: 10.1074/jbc.C300520200
Zhang Y, Zheng N, Hao P, Cao Y, Zhong Y (2005) A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2. Comput Biol Chem 29(3):254–257
pubmed: 15979045 pmcid: 7106554 doi: 10.1016/j.compbiolchem.2005.04.008
Pöhlmann S, Gramberg T, Wegele A, Pyrc K, van der Hoek L, Berkhout B et al (2006) Interaction between the spike protein of human coronavirus NL63 and its cellular receptor ACE2. Adv Exp Med Biol 581:281–284
pubmed: 17037543 pmcid: 7123575 doi: 10.1007/978-0-387-33012-9_47
Smith M, Tusell S, Travanty EA, Berkhout B, van der Hoek L, Holmes KV (2006) Human angiotensin-converting enzyme 2 (ACE2) is a receptor for human respiratory coronavirus NL63. Adv Exp Med Biol 581:285–288
pubmed: 17037544 pmcid: 7123733 doi: 10.1007/978-0-387-33012-9_48
Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A et al (2020) Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. https://doi.org/10.1101/2020.02.19.956235
Oudit G, Kassiri Z, Jiang C, Liu P, Poutanen S, Penninger J et al (2009) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Investig 39(7):618–625
doi: 10.1111/j.1365-2362.2009.02153.x
Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82(15):7264–7275
pubmed: 18495771 pmcid: 2493326 doi: 10.1128/JVI.00737-08
Dong W, Bai B, Lin Y, Gao J, Yu N (2008) Detection of the mRNA expression of human angiotensin-converting enzyme 2 as a SARS coronavirus functional receptor in human femoral head. Nan Fang Yi Ke Da Xue Xue Bao 28(3):441–443
pubmed: 18359708
Yang XH, Deng W, Tong Z, Liu YX, Zhang LF, Zhu H et al (2007) Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. Comp Med 57(5):450–459
pubmed: 17974127
Tseng C-TK, Huang C, Newman P, Wang N, Narayanan K, Watts DM et al (2007) Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 virus receptor. J Virol 81(3):1162–1173
pubmed: 17108019 doi: 10.1128/JVI.01702-06
Ren X, Glende J, Al-Falah M, de Vries V, Schwegmann-Wessels C, Qu X et al (2006) Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J Gen Virol 87(6):1691–1695
pubmed: 16690935 doi: 10.1099/vir.0.81749-0
Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203(2):631–637
pubmed: 15141377 pmcid: 7167720 doi: 10.1002/path.1570
Lei C, Fu W, Qian K, Li T, Zhang S, Ding M et al (2020) Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig. bioRxiv. https://doi.org/10.1101/2020.02.01.929976
Wang S, Guo F, Liu K, Wang H, Rao S, Yang P et al (2008) Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. Virus Res 136(1–2):8–15
pubmed: 18554741 pmcid: 7114441 doi: 10.1016/j.virusres.2008.03.004
Lu CY, Huang HY, Yang TH, Chang LY, Lee CY, Huang LM (2008) siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells. Eur J Clin Microbiol Infect Dis 27(8):709–715
pubmed: 18449585 pmcid: 7088151 doi: 10.1007/s10096-008-0495-5
Haga S, Yamamoto N, Nakai-Murakami C, Osawa Y, Tokunaga K, Sata T et al (2008) Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry. Proc Natl Acad Sci USA105(22):7809-7814
Zhang Y, Wang W, Gao J-r, Ye L, X-n F, Y-c Z et al (2007) The functional motif of SARS-CoV S protein involved in the interaction with ACE2. Virol Sin 22(1):1–7
doi: 10.1007/s12250-007-0054-8
Yan X, Shen H, Feng Y, Wang J, Lou S, Wang L et al (2007) Potent inhibition of viral entry and replication of SARS-CoV by siRNAs targeting the genes encoding the cellular ACE2 receptor or the viral nucleocapsid protein. Antivir Res 74(3):A30–A31
doi: 10.1016/j.antiviral.2007.01.018
Ho TY, Wu SL, Chen JC, Wei YC, Cheng E, Chang YH et al (2006) Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. Antivir Res 69(2):70–76
pubmed: 16337697 doi: 10.1016/j.antiviral.2005.10.005
He L, Ding Y, Zhang Q, Che X, He Y, Shen H et al (2006) Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol 210(3):288–297
pubmed: 17031779 pmcid: 7167655 doi: 10.1002/path.2067
Han DP, Penn-Nicholson A, Cho MW (2006) Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology 350(1):15–25
pubmed: 16510163 pmcid: 7111894 doi: 10.1016/j.virol.2006.01.029
Moore MJ, Dorfman T, Li W, Wong SK, Li Y, Kuhn JH et al (2004) Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J Virol 78(19):10628–10635
pubmed: 15367630 pmcid: 516384 doi: 10.1128/JVI.78.19.10628-10635.2004
Hofmann H, Geier M, Marzi A, Krumbiegel M, Peipp M, Fey GH et al (2004) Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem Biophys Res 319(4):1216–1221
doi: 10.1016/j.bbrc.2004.05.114
Prabakaran P, Xiao X, Dimitrov DS (2004) A model of the ACE2 structure and function as a SARS-CoV receptor. Biochem Biophys Res 314(1):235–241
doi: 10.1016/j.bbrc.2003.12.081
Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H et al (2020) Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol 92(6):595–601
pubmed: 32100877 doi: 10.1002/jmv.25726
Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X et al (2020) Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov 6(1):1–4
doi: 10.1038/s41421-020-0147-1
Hou Y, Peng C, Yu M, Li Y, Han Z, Li F et al (2010) Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry. Arch Virol 155(10):1563–1569
pubmed: 20567988 pmcid: 7086629 doi: 10.1007/s00705-010-0729-6
Guo H, Guo A, Wang C, Yan B, Lu H, Chen H (2008) Expression of feline angiotensin converting enzyme 2 and its interaction with SARS-CoV S1 protein. Res Vet Sci 84(3):494–496
pubmed: 17658563 doi: 10.1016/j.rvsc.2007.05.011
Chen Y, Liu L, Wei Q, Zhu H, Jiang H, Tu X et al (2008) Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques. Virology 381(1):89–97
pubmed: 18801550 pmcid: 7103406 doi: 10.1016/j.virol.2008.08.016
Fukushi S, Mizutani T, Sakai K, Saijo M, Taguchi F, Yokoyama M et al (2007) Amino acid substitutions in the s2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells. J Virol 81(19):10831–10834
pubmed: 17652383 pmcid: 2045470 doi: 10.1128/JVI.01143-07
Li W, Greenough TC, Moore MJ, Vasilieva N, Somasundaran M, Sullivan JL et al (2004) Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2. J Virol 78(20):11429–11433
pubmed: 15452268 pmcid: 521845 doi: 10.1128/JVI.78.20.11429-11433.2004
Othman H, Bouslama Z, Brandenburg J-T, Da Rocha J, Hamdi Y, Ghedira K et al (2020) In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism. bioRxiv. https://doi.org/10.1101/2020.03.04.976027
Brielle ES, Schneidman D, Linial M (2020) The SARS-CoV-2 exerts a distinctive strategy for interacting with the ACE2 human receptor. bioRxiv. https://doi.org/10.1101/2020.03.10.986398
Song W, Gui M, Wang X, Xiang Y (2018) Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog 14(8):e1007236. https://doi.org/10.1371/journal.ppat.1007236
doi: 10.1371/journal.ppat.1007236 pubmed: 30102747 pmcid: 6107290
Dijkman R, Jebbink MF, Deijs M, Milewska A, Pyrc K, Buelow E et al (2012) Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. J Gen Virol 93(9):1924–1929
pubmed: 22718567 doi: 10.1099/vir.0.043919-0
Wu K, Chen L, Peng G, Zhou W, Pennell CA, Mansky LM et al (2011) A virus-binding hot spot on human angiotensin-converting enzyme 2 is critical for binding of two different coronaviruses. J Virol 85(11):5331–5337
pubmed: 21411533 pmcid: 3094985 doi: 10.1128/JVI.02274-10
Glowacka I, Bertram S, Herzog P, Pfefferle S, Steffen I, Muench MO et al (2010) Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol 84(2):1198–1205
pubmed: 19864379 doi: 10.1128/JVI.01248-09
Chen IY, Chang SC, Wu HY, Yu TC, Wei WC, Lin S et al (2010) Upregulation of the chemokine (CC motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway. J Virol 84(15):7703–7712
pubmed: 20484496 pmcid: 2897593 doi: 10.1128/JVI.02560-09
Haga S, Nagata N, Okamura T, Yamamoto N, Sata T, Yamamoto N et al (2010) TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. Antivir Res 85(3):551–555
pubmed: 19995578 doi: 10.1016/j.antiviral.2009.12.001
Lin HX, Feng Y, Wong G, Wang L, Li B, Zhao X et al (2008) Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD–ACE2 receptor interaction. J Gen Virol 89(4):1015–1024
pubmed: 18343844 doi: 10.1099/vir.0.83331-0
Mathewson AC, Bishop A, Yao Y, Kemp F, Ren J, Chen H et al (2008) Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2. J Gen Virol 89(Pt 11):2741–2745
pubmed: 18931070 pmcid: 2886958 doi: 10.1099/vir.0.2008/003962-0
Glende J, Schwegmann-Wessels C, Al-Falah M, Pfefferle S, Qu X, Deng H et al (2008) Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Virology 381(2):215–221
pubmed: 18814896 pmcid: 7103374 doi: 10.1016/j.virol.2008.08.026
Li W, Sui J, Huang I-C, Kuhn JH, Radoshitzky SR, Marasco WA et al (2007) The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology 367(2):367–374
pubmed: 17631932 pmcid: 2693060 doi: 10.1016/j.virol.2007.04.035
Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI et al (2005) Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 280(34):30113–30119
pubmed: 15983030 doi: 10.1074/jbc.M505111200
Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S et al (2005) Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J 24(8):1634–1643
pubmed: 15791205 pmcid: 1142572 doi: 10.1038/sj.emboj.7600640
Ji X, Zhang C, Zhai Y, Zhang Z, Xue Y, Zhang C et al (2020) TWIRLS, an automated topic-wise inference method based on massive literature, suggests a possible mechanism via ACE2 for the pathological changes in the human host after coronavirus infection. medRxiv. https://doi.org/10.1101/2020.02.27.967588
Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367(6485):1444–1448
pubmed: 7164635 pmcid: 7164635 doi: 10.1126/science.abb2762
Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S (2014) TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 88(2):1293–1307
pubmed: 24227843 pmcid: 3911672 doi: 10.1128/JVI.02202-13
Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8(5):475–481
pubmed: 32105632 pmcid: 32105632 doi: 10.1016/S2213-2600(20)30079-5
Li W, Wong S-K, Li F, Kuhn JH, Huang I-C, Choe H et al (2006) Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol 80(9):4211–4219
pubmed: 16611880 pmcid: 1472041 doi: 10.1128/JVI.80.9.4211-4219.2006
Batlle D, Wysocki J, Satchell K (2020) Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci 134(5):543–545
doi: 10.1042/CS20200163
Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH et al (2005) Bats are natural reservoirs of SARS-like coronaviruses. Science 310(5748):676–679
pubmed: 16195424 pmcid: 16195424 doi: 10.1126/science.1118391
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF (2020) The proximal origin of SARS-CoV-2. Nat Med 26(4):450–452
pubmed: 32284615 pmcid: 32284615 doi: 10.1038/s41591-020-0820-9
Liu P, Jiang JZ, Wan XF, Hua Y, Li L, Zhou J et al (2020) Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLoS Pathog 16(5):e1008421. https://doi.org/10.1371/journal.ppat.1008421
doi: 10.1371/journal.ppat.1008421 pubmed: 32407364 pmcid: 7224457
He J, Tao H, Yan Y, Huang SY, Xiao Y (2020) Molecular mechanism of evolution and human infection with SARS-CoV-2. Viruses 12(4):428. Published online 2020. https://doi.org/10.3390/v12040428
doi: 10.3390/v12040428 pubmed: 7232534 pmcid: 7232534
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O et al (2020) Cryo-EM structure of the 2019-nCoV spike in the Prefusion conformation. Science 367(6483):1260–1263
pubmed: 32075877 pmcid: 7164637 doi: 10.1126/science.abb2507
Agarwal A, Chen A, Ravindran N, To C, Thuluvath PJ (2020) Gastrointestinal and liver manifestations of COVID-19. J Clin Exp Hepatol 10(3):263–265
pubmed: 32405183 pmcid: 7212283 doi: 10.1016/j.jceh.2020.03.001
Bostanciklioglu M (2020) Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research. Curr Neurovasc Res. https://doi.org/10.2174/1567202617666200522220509 . Online ahead of print
Geng YJ, Wei ZY, Qian HY, Huang J, Lodato R, Castriotta RJ (2020) Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol 47:107228. https://doi.org/10.1016/j.carpath.2020.107228
doi: 10.1016/j.carpath.2020.107228 pubmed: 32375085 pmcid: 7162778
Gurwitz D (2020) Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. https://doi.org/10.1002/ddr.21656 . Online ahead of print
Niu M, Wang RL, Wang ZX, Zhang P, Bai ZF, Jing J et al (2020) Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking. Zhongguo Zhong Yao Za Zhi 45(6):1213–1218
pubmed: 32281327
Seif F, Aazami H, Khoshmirsafa M, Kamali M, Mohsenzadegan M, Pornour M et al (2020) JAK inhibition as a new treatment strategy for patients with COVID-19. Int Arch Allergy Immunol 11:1–9. https://doi.org/10.1159/000508247 . Online ahead of print
doi: 10.1159/000508247
Saber-Ayad M, Saleh MA, Abu-Gharbieh E (2020) The rationale for potential pharmacotherapy of COVID-19. Pharmaceuticals (Basel) 13(5):E96. https://doi.org/10.3390/ph13050096
doi: 10.3390/ph13050096
Ameratunga R, Lehnert K, Leung E, Comoletti D, Snell R, Woon ST et al (2020) Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection. N Z Med J 133(1515):112–118
pubmed: 32438383

Auteurs

Asma Shojaee (A)

Student Research Committee, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Amir Vahedian-Azimi (A)

Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran. amirvahedian63@gmail.com.

Fakhrudin Faizi (F)

Atherosclerosis research center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Farshid Rahimi-Bashar (F)

Anesthesia and Critical Care Department, Hamadan University of Medical Sciences, Hamadan, Iran.

Alireza Shahriary (A)

Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Hadi Esmaeili Gouvarchin Galeh (HEG)

Applied virology research center, Baqiyatallah University of medical science, Tehran, Iran.

Batool Nehrir (B)

Health Management Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Paul C Guest (PC)

Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil.

Amirhossein Sahebkar (A)

Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com.
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. amir_saheb2000@yahoo.com.
Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. amir_saheb2000@yahoo.com.
Halal Research Center of IRI, FDA, Tehran, Iran. amir_saheb2000@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Peptide hydrolases › Exopeptidases › Carboxypeptidases › Angiotensin-converting enzyme 2 › Relationship Between COVID-19 and...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Relationship Between COVID-19 and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Relationship Between COVID-19 and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Relationship Between COVID-19 and...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Peptide hydrolases › Exopeptidases › Dipeptidyl-Peptidases and Tripeptidyl-Peptidases › Peptidyl-Dipeptidase A › Relationship Between COVID-19 and...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Relationship Between COVID-19 and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Protéines virales structurales › Protéines de l'enveloppe virale › Protéines de fusion virale › Glycoprotéine de spicule des coronavirus › Relationship Between COVID-19 and...